Edarbi and Prednisone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Edarbi (azilsartan medoxomil) and Prednisone (prednisone). Common drug interactions include alopecia among females and bladder disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Edarbi and Prednisone. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Edarbi?

Edarbi has active ingredients of azilsartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 404 Edarbi users. Check the latest studies of Edarbi.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

On Jul, 11, 2026

15 people who take Edarbi and Prednisone together, and have interactions are studied.

Edarbi and Prednisone drug interactions.

What are the common drug interactions of Edarbi and Prednisone, by gender? *:

female:

Alopecia (absence of hair from areas of the body)
Hair colour changes
Nausea (feeling of having an urge to vomit)
Thyroid disorder (thyroid diseases)
Fatigue (feeling of tiredness)
Drug ineffective
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Arthralgia (joint pain)
Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Abasia (inability to walk)

male:

Bladder disorder
Death
Fall
Fluid retention (an abnormal accumulation of fluid in the blood)
Joint effusion (presence of extra fluid in joint covering)
Rash
Urinary tract infection
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the common drug interactions of Edarbi and Prednisone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abasia (inability to walk)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Fatigue (feeling of tiredness)
Joint lock
Muscle spasms (muscle contraction)
Vomiting

60+:

Alopecia (absence of hair from areas of the body)
Hair colour changes
Fluid retention (an abnormal accumulation of fluid in the blood)
Joint effusion (presence of extra fluid in joint covering)
Rash
Squamous cell carcinoma (a cancer of a kind of epithelial cell)
Urinary tract infection
Arthralgia (joint pain)
Arthropathy
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 4 people, 26.67%
Dry Eyes (lack of adequate tears): 3 people, 20.00%
Prostate Cancer: 3 people, 20.00%
Pain: 2 people, 13.33%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 6.67%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 6.67%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 6.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 6.67%
Dizziness: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Edarbi and Prednisone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously